IL141324A0 - Improved omeprazole process and compositions thereof - Google Patents

Improved omeprazole process and compositions thereof

Info

Publication number
IL141324A0
IL141324A0 IL14132499A IL14132499A IL141324A0 IL 141324 A0 IL141324 A0 IL 141324A0 IL 14132499 A IL14132499 A IL 14132499A IL 14132499 A IL14132499 A IL 14132499A IL 141324 A0 IL141324 A0 IL 141324A0
Authority
IL
Israel
Prior art keywords
seeding
compositions
omeprazole
aqueous
residual
Prior art date
Application number
IL14132499A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22254872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL141324(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL141324A0 publication Critical patent/IL141324A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14132499A 1998-08-11 1999-08-06 Improved omeprazole process and compositions thereof IL141324A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9603798P 1998-08-11 1998-08-11
PCT/US1999/017970 WO2000009497A1 (en) 1998-08-11 1999-08-06 Improved omeprazole process and compositions thereof

Publications (1)

Publication Number Publication Date
IL141324A0 true IL141324A0 (en) 2002-03-10

Family

ID=22254872

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14132499A IL141324A0 (en) 1998-08-11 1999-08-06 Improved omeprazole process and compositions thereof
IL141324A IL141324A (en) 1998-08-11 2001-02-07 The process of beating omeprazole, omeprazole obtained from this process, preparations and pharmaceutical preparations containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141324A IL141324A (en) 1998-08-11 2001-02-07 The process of beating omeprazole, omeprazole obtained from this process, preparations and pharmaceutical preparations containing it

Country Status (18)

Country Link
US (2) US6166213A (xx)
EP (1) EP1104417B1 (xx)
JP (1) JP2002522537A (xx)
KR (1) KR100632725B1 (xx)
CN (1) CN1227246C (xx)
AT (1) ATE360626T1 (xx)
AU (1) AU764642B2 (xx)
BR (1) BR9912883A (xx)
CA (1) CA2338967A1 (xx)
DE (1) DE69935915T2 (xx)
DK (1) DK1104417T3 (xx)
ES (1) ES2285857T3 (xx)
IL (2) IL141324A0 (xx)
NO (1) NO321054B1 (xx)
NZ (1) NZ509798A (xx)
PT (1) PT1104417E (xx)
WO (1) WO2000009497A1 (xx)
ZA (1) ZA200101140B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6303787B1 (en) * 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
IL142703A (en) * 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
KR100873419B1 (ko) * 2002-06-18 2008-12-11 페어차일드코리아반도체 주식회사 높은 항복 전압, 낮은 온 저항 및 작은 스위칭 손실을갖는 전력용 반도체 소자
AU2003258335A1 (en) * 2002-08-21 2004-03-11 Teva Pharmaceutical Industries Ltd. A method for the purification of lansoprazole
EP1837335A1 (en) * 2002-08-21 2007-09-26 Teva Pharmaceutical Industries Ltd A method for the purification of Lansoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
SI1802584T1 (sl) * 2004-10-11 2010-01-29 Ranbaxy Lab Ltd Postopki za pripravo substituiranih sulfoksidov
US20060210637A1 (en) * 2005-03-17 2006-09-21 Qpharma, Llc Stable tablet dosage forms of proton pump inhibitors
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
US7598273B2 (en) * 2005-10-06 2009-10-06 Auspex Pharmaceuticals, Inc Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
WO2007066202A1 (en) * 2005-12-06 2007-06-14 Inogent Laboratories Private Limited Process for the preparation of 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
US20090280175A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Proton Pump Inhibitor Tablets
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN103204841B (zh) * 2013-05-09 2014-06-25 成都天台山制药有限公司 奥美拉唑钠及制备方法
CN104592201A (zh) * 2015-01-13 2015-05-06 江苏中邦制药有限公司 一种奥美拉唑的精制方法
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
CN111635393A (zh) * 2020-06-28 2020-09-08 江苏吴中医药集团有限公司 一种艾司奥美拉唑钠的制备方法
CN112679475B (zh) * 2021-01-14 2022-02-15 四川新迪医药化工有限公司 一种奥美拉唑的制备方法及奥美拉唑
WO2023048508A1 (ko) * 2021-09-23 2023-03-30 국립암센터 오메프라졸 갈변물질을 포함하는 암 예방 또는 치료용 약학적 조성물
CN114209697A (zh) * 2021-12-14 2022-03-22 重庆大学附属三峡医院 一种质子泵抑制剂、制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
GB2239453A (en) * 1989-11-27 1991-07-03 Haessle Ab Omeprazole
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
WO1993006097A1 (en) * 1991-09-20 1993-04-01 Merck & Co., Inc. Novel process for the preparation of anti-ulcer agents
TW359614B (en) * 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
WO1996038175A1 (en) * 1995-06-02 1996-12-05 Takeda Chemical Industries, Ltd. Stabilized composition comprising an antiulcerative benzimidazole
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
AU5982298A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos
AU5982198A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos

Also Published As

Publication number Publication date
CA2338967A1 (en) 2000-02-24
JP2002522537A (ja) 2002-07-23
ES2285857T3 (es) 2007-11-16
DE69935915T2 (de) 2008-01-10
EP1104417A4 (en) 2002-12-18
CN1227246C (zh) 2005-11-16
EP1104417B1 (en) 2007-04-25
CN1322201A (zh) 2001-11-14
KR100632725B1 (ko) 2006-10-16
AU5470999A (en) 2000-03-06
DE69935915D1 (de) 2007-06-06
NZ509798A (en) 2003-06-30
AU764642B2 (en) 2003-08-28
EP1104417A1 (en) 2001-06-06
ATE360626T1 (de) 2007-05-15
NO20010677L (no) 2001-04-09
NO321054B1 (no) 2006-03-06
BR9912883A (pt) 2001-09-25
KR20010072382A (ko) 2001-07-31
DK1104417T3 (da) 2007-07-16
NO20010677D0 (no) 2001-02-09
IL141324A (en) 2007-05-15
US6147103A (en) 2000-11-14
WO2000009497A1 (en) 2000-02-24
US6166213A (en) 2000-12-26
PT1104417E (pt) 2007-06-29
ZA200101140B (en) 2002-04-09

Similar Documents

Publication Publication Date Title
IL141324A0 (en) Improved omeprazole process and compositions thereof
US5386032A (en) Method of synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl-1H-benzimidazole (omeprazole)
CA1215708A (en) New process for the synthesis of pyrido-imidazo- rifamycins
CA1142943A (en) 4-guanidinomethylcyclohexane carboxylic acid compounds
Chandrasekhar et al. Neighbouring group assisted sulfonamide cleavage of Sharpless aminols under acetonation conditions
AU2006242782B2 (en) New process for synthesis of proton pump inhibitors
FR2557111A1 (fr) Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
AU7949900A (en) Process for producing optically active naphthalene derivative and optical resolver therefor
US5574155A (en) Process for the synthesis of the disodium salt hemiheptahydrate of ceftriaxone
Leland et al. Analgesic narcotic antagonists. 5. 7, 7-Dimethyldihydrocodeinones and 7, 7-dimethyldihydromorphinones
CA2131648A1 (en) Process of making a benzothiadiazole derivative
Barluenga et al. Regiospecific synthesis of isoxazoles by reaction of 1-azabutadiene derivatives with hydroxylamine hydrochloride
JP2583062B2 (ja) 複素環化合物の製造法
US4125711A (en) Process for preparing auranofin
KR910008938B1 (ko) 피리딘 유도체의 제조방법
Crowe et al. The preparation of 14C, 35S and 13C labelled forms of omeprazole
CA1261838A (en) ¬2-¬2-(5-dimethylaminomethylfuran-2-ylmethylthio) -ethylamino-5-(2-methoxypyrid-4-ylmethyl) pyrimidim-4-one|
KR930003491B1 (ko) 아미노 글리코시드의 제조방법
IL98852A (en) Process for the preparation of sulfinylpristinamycin BII
Vijayabaskar et al. Stereoselective synthesis of oxiranes from substituted 4-piperidones and a tetrahydro-4-thiapyranone
JPS6440468A (en) Novel indenoimidazole derivative
KR950032214A (ko) 세펨 유도체의 제조방법
JPS55151547A (en) Production of guanidinocapronic ester
CS235429B1 (cs) Způsob výroby 5-/2-(N.N-Dimethylamino)ethoxy/7-oxo-7H-benzo/c/fluorenhydrochloridu
HU207323B (en) New process for producing nicotinic acid esters of morphine derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed